Open-Label Extension Studies: Are They Really Research?

American Journal of Bioethics 14 (4):60-61 (2014)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/15265161.2014.889958

Other Versions

original Cho, Mildred K. (2014) "Open-Label Extension Studies: Are They Really Research?". American Journal of Bioethics 14(3):1-2

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,636

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Open-Label Extension Studies: Are They Really Research?Mildred K. Cho - 2014 - American Journal of Bioethics 14 (3):1-2.
When Should Open-Label Extension Studies Be Stopped?Joshua S. Crites - 2014 - American Journal of Bioethics 14 (4):57-58.
Ethics of Continuing to Provide a Drug on an Open-Label Extension Study for an “Unapproved Indication”.Holly A. Taylor, Ellen Kuwana & Benjamin S. Wilfond - 2014 - American Journal of Bioethics 14 (4):56-56.
Open Label Extension Studies & the Ethical Design of Clinical Trials.David Casarett, Jason Karlawish, Pamela Sankar, Karen B. Hirschman & David A. Asch - 2001 - IRB: Ethics & Human Research 23 (4):1.
Consent to open label extension studies: some ethical issues.P. Wainwright - 2002 - Journal of Medical Ethics 28 (6):373-376.
Design, objectives, execution and reporting of published open‐label extension studies.Bowers Megan, Ruth M. Pickering & Mark Weatherall - 2012 - Journal of Evaluation in Clinical Practice 18 (2):209-215.
The Role of Clinical Equipoise and Practical Considerations in Deciding Whether to Continue to Provide a Drug on an Open-Label Extension Study for an “Unapproved Indication”.Ryan R. Nash - 2014 - American Journal of Bioethics 14 (4):59-60.
Open label extension studies and patient selection biases.Karla Hemming, Jane L. Hutton, Melissa J. Maguire & Anthony G. Marson - 2008 - Journal of Evaluation in Clinical Practice 14 (1):141-144.
AI-Based Medical Solutions Can Threaten Physicians’ Ethical Obligations Only If Allowed to Do So.Benjamin Gregg - 2023 - American Journal of Bioethics 23 (9):84-86.
Enabling the Nonhypothesis-Driven Approach: On Data Minimalization, Bias, and the Integration of Data Science in Medical Research and Practice.C. W. Safarlou, M. van Smeden, R. Vermeulen & K. R. Jongsma - 2023 - American Journal of Bioethics 23 (9):72-76.

Analytics

Added to PP
2017-02-17

Downloads
16 (#1,197,550)

6 months
4 (#1,260,583)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Citations of this work

Post-trial access to treatment: corporate best practices.Irene Schipper & Silvia Colona - 2015 - SOMO Centre for Research on Multinational Corporations.

Add more citations

References found in this work

The UNESCO Declaration on Bioethics and Human Rights: A Canon for the Ages?G. Trotter - 2009 - Journal of Medicine and Philosophy 34 (3):195-203.
Consent to open label extension studies: some ethical issues.P. Wainwright - 2002 - Journal of Medical Ethics 28 (6):373-376.

View all 7 references / Add more references